EUVIMEDOpdag EUVIMED
Crossref

Agile 3+ Index Is Independently Associated With Cardiovascular Diseases in Patients With Metabolic Dysfunction‐Associated Steatotic Liver Disease: Analysis of NHANES 2017–2020

Yan Li iD, Minglan Yang, Jiang Yue, Zixuan Wang, Yicheng Qi, Qianjing Liu, Jing Ma iD

Diabetes/Metabolism Research and Reviews · 2026

DOI: 10.1002/dmrr.70123 ↗

At a glance

Journal article in Diabetes/Metabolism Research and Reviews, 2026. Written by Yan Li and 6 co-authors. Institution: Department of Endocrinology and Metabolism, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. Major MEDLINE topics: Cardiovascular Diseases, Biomarkers, Non-alcoholic Fatty Liver Disease, Metabolic Diseases. 36 references. Funded by: China International Medical Foundation, Noncommunicable Chronic Diseases-National Science and Technology Major Project, 2024 Shanghai Oriental Talents - Technology Platform Program.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

The Agile 3+ score, recently developed based on transient elastography measurements, transaminase ratios, and metabolic parameters, effectively assesses fibrosis in metabolic dysfunction‐associated steatotic liver disease (MASLD). This study aimed to evaluate the association between Agile 3+ and cardiovascular diseases (CVD) in MASLD and to compare its predictive performance with Agile 4, Fibrosis‐4 (FIB‐4), and FibroScan aspartate aminotransferase (FAST).

Methods

We analysed data in 3198 patients with MASLD during the 2017–March 2020 prepandemic from National Health and Nutrition Examination Survey. The associations between Agile 3+ and CVD were assessed using univariate and multivariable logistic regression models. Predictive accuracy was evaluated via receiver operating characteristic curves and decision curve analysis (DCA).

Results

Among 3198 patients with MASLD, 385 (12.0%) had CVD. After adjusting for confounders, a dose‐dependent relationship was observed between Agile 3+ and CVD risk: compared to the reference group, the odds of CVD increased by 58% in the 0.45–0.68 group (OR 1.58, 95%CI 1.13–2.20, p = 0.008) and by 78% in the ≥ 0.68 group (OR 1.78, 95%CI 1.22–2.59, p = 0.003). In the context of CVD risk prediction, Agile 3+ and FIB‐4 achieved the highest AUC (0.71), outperforming Agile 4 (0.64) and FAST (0.51). DCA revealed that Agile 3+ provided superior net benefit within the 20%–40% CVD risk threshold range. Furthermore, subgroup and sensitivity analyses further confirmed the robustness of the results.

Conclusions

Agile 3+ is independently associated with CVD in patients with MASLD and demonstrates better predictive performance than Agile 4, FIB‐4, and FAST scores.

Subjects

MeSH terms (MEDLINE)

Cardiovascular DiseasesBiomarkersNon-alcoholic Fatty Liver DiseaseMetabolic DiseasesFatty LiverLiver CirrhosisHumansFemaleMaleMiddle AgedNutrition SurveysPrognosisElasticity Imaging TechniquesRisk FactorsFollow-Up StudiesROC CurveAdultUnited StatesCross-Sectional Studies

Author keywords

Agile 3+DCANHANEScardiovascular diseasemetabolic dysfunction‐associated steatotic liver disease

Substances

Biomarkers

Authors and institutions

  • Department of Endocrinology and Metabolism, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

ORCID profiles: Yan Li, Jing Ma

Funding

  • China International Medical Foundation
  • Noncommunicable Chronic Diseases-National Science and Technology Major Project
  • 2024 Shanghai Oriental Talents - Technology Platform Program
  • National Major Science and Technology Projects of China

Cite

APA

Li, Y., Yang, M., Yue, J., Wang, Z., Qi, Y., Liu, Q., & Ma, J. (2026). Agile 3+ Index Is Independently Associated With Cardiovascular Diseases in Patients With Metabolic Dysfunction‐Associated Steatotic Liver Disease: Analysis of NHANES 2017–2020. Diabetes/Metabolism Research and Reviews. https://doi.org/10.1002/dmrr.70123

Vancouver

Li Y, Yang M, Yue J, Wang Z, Qi Y, Liu Q, et al. Agile 3+ Index Is Independently Associated With Cardiovascular Diseases in Patients With Metabolic Dysfunction‐Associated Steatotic Liver Disease: Analysis of NHANES 2017–2020. Diabetes/Metabolism Research and Reviews. 2026. doi:10.1002/dmrr.70123

BibTeX
@article{Li2026,
  author = {Li, Yan and Yang, Minglan and Yue, Jiang and Wang, Zixuan and Qi, Yicheng and Liu, Qianjing and Ma, Jing},
  title = {Agile 3+ Index Is Independently Associated With Cardiovascular Diseases in Patients With Metabolic Dysfunction‐Associated Steatotic Liver Disease: Analysis of NHANES 2017–2020},
  journal = {Diabetes/Metabolism Research and Reviews},
  year = {2026},
  doi = {10.1002/dmrr.70123}
}
Start for free →